2nd Annual International AMNOG Summit 2013

After the success of the 2012 launch of Europe’s first english language AMNOG summit, we are returning with more speakers, more workshops and more case studies.

• Hear over 50 G-BA decisions deconstructed: get insight into the critical success factors and get the latest update on upcoming decisions and development
• Don't miss the first ever dedicated early benefit assessment workshop for Medical Devices
• Get your chance to meet the payer and learn how to engage, communicate with and influence payers in Germany.
• Develop effective communication channels with AMNOG decision makers and ensure early benefit assessment success in Germany
• Understand how to convert early benefit assessment success into real market share.

Make sure that you are the first to see the full agenda and programme here

• AMNOG – is it a fair assessment process? Tips on how to influence
• How to make a successful IQWiG assessment
• Understand the roadmap – learn what comes after IQWiG assessment
• The do's and don'ts in pricing negotiations with the GKV Spitzenverband
• Last chance arbitration? A best-practice guide
• Essential G-BA scientific advice
• Generating a benefit dossier and its financial burden
• IQWiG assessment process. "Slicing" - IQWiG's new approach for drug assessments?
• The G-BA assessment process and price negotiations with the GKV Spitzenverband
• How important is Health Economics in the context of AMNOG? How to gather the right data to overcome the AMNOG hurdle

Here is a selected list of the 100+ executives who joined us last October. Find out who will be there in April

For more information, or if you'd like to get involved contact Thomas Disley, the Event Co-ordinator, on the details below.

Thomas Disley

Global Events Director,
eyeforpharma

T: +44 207 375 7583

E: tdisley@eyeforpharma.com